OOIR: Observatory of International Research

Papers

(The H4-Index of Best Practice & Research Clinical Endocrinology & Metabolism is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Myeloma and marrow adiposity: Unanswered questions and future directions	102
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”	101
Editorial Board	68
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	65
Editorial Board	52
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	52
Editorial Board	51
Menopausal hormone therapy for the management of osteoporosis	50
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	47
Genetics of pubertal timing	43
Regulation of bone mass: A splendid Orchestra	42
Coronavirus disease 2019 and vitamin D	40
Editorial Board	38
The role of androgens in transgender medicine	37
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	37
Rare forms of genetic steroidogenic defects affecting the gonads and adrenals	37
Sexual health and contraception in the menopause journey	36
Prenatal exposure to phthalate esters and its impact on child development	35
Editorial Board	34
Immune checkpoint inhibitor-related thyroid dysfunction	34
Remnant lipoprotein particles and cardiovascular disease risk	33
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications	32
Cardiometabolic outcomes of early onset hypogonadism in males	31
Haematological actions of androgens	28
Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis	27

Type 1 diabetes related to immune checkpoint inhibitors	27
Bone marrow adiposity and the hematopoietic niche: A historical perspective of reciprocity, heterogeneity, and lineage commitment	26
Endocrine-disrupting chemicals and behaviour: A high risk to take?	26
Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia	26